See All Slides - tctmd.com

Slides

Presentation TCT 2025

TCT 1918: Hybrid Therapy for Acute Upper Limb Ischemia With Thoracic Outlet Syndrome: A Case Report

Presenter: Eiji Koyama

October 27, 2025

Presentation TCT 2025

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

Presenter: Xiaochun Zhang

October 27, 2025

Presentation TCT 2025

In Intermediate-risk PE, What Measurable Improvements Can Catheter-Based Therapy Offer Over Anticoagulation??

Presenter: Suhail Dohad

October 27, 2025

Presentation TCT 2025

Reperfuse First and Avoid Bleeding

Presenter: Vijay Kunadian

October 27, 2025

Presentation TCT 2025

Who’s the Right Patient? Interpreting Trials and Guidelines

Presenter: Matthew J. Price

October 27, 2025

Presentation TCT 2025

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

Presenter: Fabien Praz

October 27, 2025

Presentation TCT 2025

AI Agents in the Cath Pathway: AI Outreach for Patient Readiness and Recovery

Presenter: Derek A. Pineda

October 27, 2025

Presentation TCT 2025

My Tips and Tricks for Mitral LVOT Obstruction and Leaflet Modification

Presenter: David Daniels

October 27, 2025

Presentation TCT 2025

TCT 1205: Contemporary Trends in In-Hospital Mortality in Patients with NSTEMI Stratified by Early Versus Late Percutaneous Coronary Intervention

Presenter: Chaitanya Tumuluri

October 27, 2025

Presentation TCT 2025

TCT 107: Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention according to clinical risk and lesion complexity

Presenter: Seokhun Yang

October 27, 2025

Advertisement

Slides

TCT 1918: Hybrid Therapy for Acute Upper Limb Ischemia With Thoracic Outlet Syndrome: A Case Report

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

In Intermediate-risk PE, What Measurable Improvements Can Catheter-Based Therapy Offer Over Anticoagulation??

Reperfuse First and Avoid Bleeding

Who’s the Right Patient? Interpreting Trials and Guidelines

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

AI Agents in the Cath Pathway: AI Outreach for Patient Readiness and Recovery

My Tips and Tricks for Mitral LVOT Obstruction and Leaflet Modification

TCT 1205: Contemporary Trends in In-Hospital Mortality in Patients with NSTEMI Stratified by Early Versus Late Percutaneous Coronary Intervention

TCT 107: Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention according to clinical risk and lesion complexity

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content